FDA approval reportedly came after Trump pressure. Public health experts are concerned about overall vape safety and politics overruling science.
The move comes after the acting Center for Drug Evaluation and Research director Tracy Beth Høeg disagreed with a staff decision.
At a Rome conference, biotech leaders warn FDA shifts are rattling gene therapy, as Europe pitches flexibility and the field eyes a recovery.
Policy recommendations in OpenAI's blueprint for unlocking AI’s potential to change healthcare are reasonable, but also self-serving, experts say.
White House estimate questioned by experts who see 10-year projections based on 3-year deals and little transparency on deals with 17 pharmaceutical giants.
Color Health, a Silicon Valley health tech company, wants to "reinvent how cancer is managed." Here's how a virtual cancer clinic would work.
Will Flanary, aka Dr. Glaucomflecken, talks advocacy, cosmetic eye surgery, and ‘Scrubs’ on the “First Opinion Podcast.”
Dementia leads to a grief known as ambiguous loss. American medicine and culture need to talk about it.
